23 results
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
Hypereosinophilia and ... suspect underlying hematologic ... Treatment Algorithm ... #HES #Hematology ... eosinophils #diagnosis #management
Diffuse large B cell lymphoma (DLBCL) - Management and Treatment Algorithm

By Matthew Ho, MD PhD @MatthewHoMD

#Diffuse
lymphoma (DLBCL) - Management ... and Treatment Algorithm ... lymphoma #DLBCL #Management ... #Treatment #Algorithm ... #oncology #hematology
Treatment Approach to Hodgkin's Lymphoma

By Matthew Ho, MD PhD @MatthewHoMD
With Credit: Dr Sunita Nasta and Dr
Treatment Approach ... Dr Sunita Nasta and ... Hodgkins #Lymphoma #oncology ... #Hematology #management ... #treatment #guideline
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Myelodysplastic Syndrome ... only curative treatment ... Myelodysplastic #Syndrome ... #treatment #hematology ... #oncology
Acquired von Willebrand Syndrome - Diagnosis and Management
 • Autoantibodies to vWF: Lymphoproliferative disorders (e.g. lymphoma,
von Willebrand Syndrome ... Management • ... vonWillebrand #Syndrome ... #Diagnosis #Management ... #treatment #hematology
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Treatment
Stop offending agents:
 • List as allergies
with Eosinophilia and ... Symptoms (DRESS) Syndrome ... Treatment Stop ... #Treatment #Management ... #dermatology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... Currently, edoxaban and ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... (A) Suggested treatment ... for symptomatic and ... Anticoagulation #Management ... #Hematology #Oncology
Melanoma Treatment Algorithm

Resectable vs Inoperable Disease

Matthew Ho, MD PhD @MatthewHoMD and Aakash Desai, MD @ADesaiMD

#Melanoma #Treatment
Melanoma Treatment ... PhD @MatthewHoMD and ... #Melanoma #Treatment ... #Algorithm #Management ... #dermatology #oncology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation Syndrome ... Triggers: ATRA treatment ... Renal Failure Treatment ... APML #diagnosis #management ... #hematology #oncology